4.6 Article

Single Turnover Autophosphorylation Cycle of the PKA RIIβ Holoenzyme

期刊

PLOS BIOLOGY
卷 13, 期 7, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pbio.1002192

关键词

-

资金

  1. National Institutes of Health [GM034921]
  2. European Union FP7 Health Programme [241481]
  3. Federal Ministry of Education and Research [0316177F]

向作者/读者索取更多资源

To provide tight spatiotemporal signaling control, the cyclic adenosine monophosphate (CAMP)-dependent protein kinase (PKA) holoenzyme typically nucleates a macromolecular complex or a PKA signalosome. Using the RII beta holoenzyme as a prototype, we show how autophosphorylation/dephosphorylation of the RII beta subunit, as well as cAMP and metal ions, contribute to the dynamics of PKA signaling. While we showed previously that the RII beta holoenzyme could undergo a single turnover autophosphorylation with adenosine triphosphate and magnesium (MgATP) and trap both products in the crystal lattice, we asked here whether calcium could trap an ATP: RII beta holoenzyme since the RII beta holoenzyme is located close to ion channels. The 2.8 angstrom structure of an RII beta p(2):C-2:(Ca(2)ADP)(2) holoenzyme, supported by biochemical and biophysical data, reveals a trapped single phosphorylation event similar to MgATP. Thus, calcium can mediate a single turnover event with either ATP or adenosine-5'-(beta,gamma-imido) triphosphate (AMP-PNP), even though it cannot support steady-state catalysis efficiently. The holoenzyme serves as a product trap because of the slow off-rate of the pRII beta subunit, which is controlled by cAMP, not by phosphorylation of the inhibitor site. By quantitatively defining the RII beta signaling cycle, we show that release of pRII beta in the presence of cAMP is reduced by calcium, whereas autophosphorylation at the phosphorylation site (P-site) inhibits holoenzyme reassociation with the catalytic subunit. Adding a single phosphoryl group to the preformed RII beta holoenzyme thus creates a signaling cycle in which phosphatases become an essential partner. This previously unappreciated molecular mechanism is an integral part of PKA signaling for type II holoenzymes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

The Tails of Protein Kinase A

Susan S. Taylor, Kristoffer Soberg, Evan Kobori, Jian Wu, Sabine Pautz, Friedrich W. Herberg, Bjorn Steen Skalhegg

Summary: Protein kinase A (PKA) is a holoenzyme consisting of regulatory (R) subunit dimers and two catalytic (C) subunits, with different families of C subunits (Ca and Cb) and four nonredundant R subunits (RIa, RIb, RIIa, RIIb). The N- and C-terminal tails of PKA influence the structure and function of the kinase core, with the Nt-tails showing combinatorial variations in Ca and Cb subunits compared to the conserved Ct-tail. The Cb isoforms, particularly Cb2 in lymphocytes, and Cb3 and Cb4 in the brain, play important and nonredundant roles in PKA signaling, with isoform-specific localization to mitochondria.

MOLECULAR PHARMACOLOGY (2022)

Review Biochemistry & Molecular Biology

Leucine rich repeat kinase 2 (LRRK2) peptide modulators: Recent advances and future directions

Leah G. Helton, Hardy J. Rideout, Friedrich W. Herberg, Eileen J. Kennedy

Summary: LRRK2 is a common genetic contributor to Parkinson's disease, with pathogenic mutations often leading to increased kinase activity that can be inhibited by small molecules, but these inhibitors are limited by toxicity. Recent research has focused on protein-protein interactions involving LRRK2 and their role in PD, with potential for constrained peptides and peptidomimetics to target LRRK2.

PEPTIDE SCIENCE (2022)

Meeting Abstract Biochemistry & Molecular Biology

The Forgotten PKAs: New Insights Revealed by the First Crystal Structure of a PKA C Beta Splice Variant, Cβ4ab

Jessica H. Bruystens, Jian Wu, Maximilian Wallbott, Daniela Bertinetti, Friedrich W. Herberg, Susan S. Taylor

FASEB JOURNAL (2022)

Article Multidisciplinary Sciences

Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2

Ranjan K. Singh, Ahmed Soliman, Giambattista Guaitoli, Eliza Stoermer, Felix von Zweydorf, Thomas Dal Maso, Asmaa Oun, Laura Van Rillaer, Sven H. Schmidt, Deep Chatterjee, Joshua A. David, Els Pardon, Thomas U. Schwartz, Stefan Knapp, Eileen J. Kennedy, Jan Steyaert, Friedrich W. Herberg, Arjan Kortholt, Christian Johannes Gloeckner, Wim Versees

Summary: Mutations in the LRRK2 gene are a leading cause of Parkinson's disease, while overactivation of LRRK2 is associated with idiopathic form of the disease. Researchers have identified and characterized nanobodies that can bind to different domains of LRRK2 and inhibit or activate its activity. These nanobodies act through an allosteric inhibitor mechanism and provide potential therapeutic strategies for Parkinson's disease.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biochemistry & Molecular Biology

Capturing the domain crosstalk in full length LRRK2 and LRRK2RCKW

Eliza Stoermer, Jui-Hung Weng, Jian Wu, Daniela Bertinetti, Pallavi Kaila Sharma, Wen Ma, Friedrich W. Herberg, Susan S. Taylor

Summary: LRR-kinase 2 (LRRK2) is a protein associated with Parkinson's Disease (PD) and its mutations influence the crosstalk between different domains of LRRK2. The kinase domain drives LRRK2 activation, and the LRR domain and LRR-COR linker hinder substrate binding in the inactive state. Removing the N-terminal domains alters intra-molecular regulation. Hydrogen-Deuterium exchange Mass Spectrometry (HDX-MS) and Gaussian Accelerated Molecular Dynamics (GaMD) techniques provide insights into the conformation and dynamics of different LRRK2 domains, revealing potential therapeutic targets.

BIOCHEMICAL JOURNAL (2023)

Article Biochemistry & Molecular Biology

Edmond Fischer's kinase legacy: History of the protein kinase inhibitor and protein kinase A

Susan S. Taylor, Friedrich W. Herberg, Gianluigi Veglia, Jian Wu

Summary: Fischer's career primarily focused on protein phosphatases, but he also showed interest in cAMP-dependent protein kinase (PKA) and the high-affinity protein kinase inhibitor (PKI). PKI is a disordered protein that binds tightly to the PKA catalytic subunit with a pseudo-substrate motif. The structure and characteristics of PKI have been studied using different complexes and motifs, including the IP20 motif and the nuclear export signal (NES). PKI and PKA have been found to be highly expressed in the brain and are linked to cancer, but their biological importance in these contexts is not yet fully understood.

IUBMB LIFE (2023)

Review Chemistry, Physical

The violin model: Looking at community networks for dynamic allostery

Lalima K. K. Madan, Colin L. L. Welsh, Alexandr P. P. Kornev, Susan S. S. Taylor

Summary: Allosteric regulation of proteins is an engaging research topic that has evolved from focusing on structural changes to considering internal protein dynamics. The violin model, based on redistribution of protein thermal fluctuations, utilizes graph theory and community network analysis to cluster correlated protein motions. This Review provides the theory and workflow of the methodology and illustrates its application to protein kinase A.

JOURNAL OF CHEMICAL PHYSICS (2023)

Article Biochemistry & Molecular Biology

Novel LRR-ROC Motif That Links the N- and C-terminal Domains in LRRK2 Undergoes an Order-Disorder Transition Upon Activation

Jui-Hung Weng, Chiara R. Trilling, Pallavi Kaila Sharma, Eliza Stoermer, Jian Wu, Friedrich W. Herberg, Susan S. Taylor

Summary: Mutations in the LRRK2 gene increase the risk of Parkinson's disease. LRRK2 is a protein kinase with seven well-folded domains. The LRR-ROC linker becomes disordered when LRRK2 is activated, and a key residue W1295 blocks substrate access. High-dynamics simulations show the stability of the LRR-Linker motif, P + 1 loop, and inhibitory helix.

JOURNAL OF MOLECULAR BIOLOGY (2023)

Article Chemistry, Medicinal

Biochemical Discovery, Intracellular Evaluation, and Crystallographic Characterization of Synthetic and Natural Product Adenosine 3?,5?-Cyclic Monophosphate-Dependent Protein Kinase A (PKA) Inhibitors

Brice A. P. Wilson, Ning Li, Juliana A. Martinez Fiesco, Masoumeh Dalilian, Dongdong Wang, Emily A. Smith, Antony Wamiru, Rohan Shah, Ekaterina I. Goncharova, John A. Beutler, Tanja Grkovic, Ping Zhang, Barry R. O'Keefe

Summary: The recent discovery of the oncogenic role of protein kinase A (PKA) in various cancers has revitalized the interest in developing drugs targeting this kinase. Therefore, a series of assays including biochemical, cell-based, and structural biology methods have been established to identify and evaluate new PKA inhibitors. The screening process involved a high-throughput screen of over 200,000 substances, followed by prioritization through biochemical, biophysical, and cell-based assays. Lead compounds with high priority were extensively characterized, which led to the identification of previously unrecognized PKA pharmacophores and the generation of new X-ray crystallography structures demonstrating unique interactions between PKA and inhibitor molecules.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

Review Biochemistry & Molecular Biology

Microtubule-Associated Serine/Threonine (MAST) Kinases in Development and Disease

Marie Rumpf, Sabine Pautz, Benedikt Drebes, Friedrich W. W. Herberg, Hans-Arno J. Mueller

Summary: MAST kinases are a conserved branch of the AGC protein kinase superfamily, with four identified family members in mammals. They play a crucial role in various human diseases, including cancer, inflammatory bowel disease, cystic fibrosis, and neuronal disorders. However, the molecular mechanisms of MAST kinases in these diseases are still not well understood.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

The PKG Inhibitor CN238 Affords Functional Protection of Photoreceptors and Ganglion Cells against Retinal Degeneration

Arianna Tolone, Wadood Haq, Alexandra Fachinger, Akanksha Roy, Sandeep Kesh, Andreas Rentsch, Sophie Wucherpfennig, Yu Zhu, John Groten, Frank Schwede, Tushar Tomar, Friedrich W. Herberg, Vasilica Nache, Francois Paquet-Durand

Summary: The study found that CN238, a cGMP analogue and PKG inhibitor, can protect photoreceptors and retinal ganglion cells from degeneration, indicating its potential for treating retinal and neurodegenerative diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Multidisciplinary Sciences

Structure and regulation of full-length human leucine-rich repeat kinase 1

Riley D. Metcalfe, Juliana A. Martinez Fiesco, Luis Bonet-Ponce, Jillian H. Kluss, Mark R. Cookson, Ping Zhang

Summary: The human leucine-rich repeat kinases (LRRKs), LRRK1 and LRRK2, are large complex kinases that regulate cellular processes and are implicated in human disease. This study reveals the structures of the LRRK1 monomer and dimer using cryo-EM, showing key interdomain interfaces that control kinase activity and structural differences to LRRK2. These findings enhance our understanding of the activation and physiological roles of LRRKs.

NATURE COMMUNICATIONS (2023)

Article Biology

Crystal Structures Reveal Hidden Domain Mechanics in Protein Kinase A (PKA)

Colin L. Welsh, Abigail E. Conklin, Lalima K. Madan

Summary: Understanding the changes in protein shape during cellular function is crucial for understanding biology. In this study, the researchers investigated the protein PKA and how its shape changes as it chemically alters other proteins. Using crystal structures of PKA, they identified regions that change shape based on interactions with ligands or other signaling proteins. These findings provide insight into PKA and protein kinase regulation, which can lead to advances in pharmacological therapies and disease biology.

BIOLOGY-BASEL (2023)

Meeting Abstract Biophysics

Influential nodes drive dynamic allostery in protein tyrosine phosphatases

Colin L. Welsh, Alexandr P. Kornev, Lalima K. Madan

BIOPHYSICAL JOURNAL (2023)

Meeting Abstract Medicine, Research & Experimental

Isoform-specific interaction profiles of human PKG and specific cGMP analogues point to novel strategies for treatment of retinal degeneration

Alexandra Fachinger, Zhan Zhou, Misheel Solongo, Philipp Henning, Arianna Tolone, Francois Paquet-Durand, Friedrich W. Herberg

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

暂无数据